Marksans Pharma rallies after good Q1 results

Total income increased marginally by 5 percent to Rs. 212 crore from Rs. 202 crore for the above mentioned period.

Marksans Pharma is trading higher on the BSE after the company reported 24.4 percent growth in consolidated net profit, which stood at Rs. 32.23 crore in Q1FY16, as against Rs. 25.91 crore in a year ago period.

Total income increased marginally by 5 percent to Rs. 212 crore from Rs. 202 crore for the above mentioned period.

The stock so far has rallied 5.7 percent to hit a high at Rs. 115 and is now up 4.1 percent at Rs. 113.

The BSE counter has witnessed trades of around 895,000 shares, when compared with two-week daily average volume of 1.5 million shares.

Meanwhile, the Sensex jumped 151 points at 28,388.